- About MHRP
- International Network
- Prevention, Care & Treatment
- News & Publications
An Army-sponsored phase III clinical trial (RV144) involving more than 16,000 adult volunteers in Thailand showed that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection.
RV217: A multi-site research study on acute HIV infections
RV254: An early HIV infection study in Thailand
RV262: Phase I study to evaluate a combination DNA prime/MVA vector boost vaccine regimen
RV305: Immunogenicity study evaluating extended boosting regimens using the same vaccine components used in RV144
RV329: African Cohort Study
MHRP's Dr. Jintanat Anaworanich heads the scientific journal and authors an editorial with Dr. Fauci on HIV cure research.
On World AIDS Day (Dec. 1), two leading HIV researchers are calling on the global community to renew the sense of urgency around developing a safe and effective vaccine against HIV/AIDS.
This prestigious award, given by Her Royal Highness Princess Soamsawali on World AIDS Day, recognizes her contributions to the advancement of HIV care and research in Thailand.
The Role of Research Nurses in HIV Research
Nurses play an integral role on the research team of HIV studies and vaccine clinical trials. Read more about two hard-working nurses who are helping MHRP in the quest to find an end to AIDS.
Video: Early HIV Infection Study Offers Insight Into the Initial Stages of HIV Infection
MHRP researchers and Thai collaborators are leading the way in acute infection studies. One study, called RV254/SEARCH 010 is providing knowledge about the earliest HIV events that may provide clues to developing an effective HIV vaccine or even help identify ways to achieve a functional cure.